16.29
0.06%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TEVA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Teva- Pharmaceutical Industries Ltd. ADR Borsa (TEVA) Ultime notizie
A company insider recently sold 15219 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale ... - Knox Daily
Knox Daily
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Has Great Upside Potential – Stocks Register - Stocks Register
Stocks Register
2024-05-15 | NYSE:TEVA | Press Release | Teva Pharmaceutical Industries ADR Representing One - Stockhouse Publishing
Stockhouse Publishing
There is no doubt that Teva- Pharmaceutical Industries Ltd. ADR (TEVA) ticks all the boxes. – Sete News - SETE News
SETE News
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
TEVA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
The InvestChronicle
TEVA's price-to-cash ratio: How it affects the stock's valuation. – US Post News - US Post News
US Post News
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks Investment Research
Teva Earnings: Despite Mixed First Quarter Results Shares Rally on Good Readout for Olanzapine - Morningstar
Morningstar
Teva's Long-Term Outlook Looks Promising on Biosimilar Wins and Growing, Innovative Portfolio - Morningstar
Morningstar
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
The Motley Fool
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research
Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High
Benzinga
Teva's Long-Term Outlook Looks Promising on Biosimilar Wins and Growing, Innovative Portfolio - Morningstar
Morningstar
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks Investment Research
Red Light, Green Light: 2 Things to Know Before Buying Teva Pharmaceutical Industries Ltd (ADR) Stoc - AOL
AOL
Understanding TEVA stock ratios for better investment decisions – US Post News - US Post News
US Post News
Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
Zacks Investment Research
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
Zacks Investment Research
Our Attention Has Been Attracted to Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) – US Post News - US Post News
US Post News
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Zacks Investment Research
Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead
The Motley Fool
3 No-Brainer Stocks to Buy With $600 Right Now
The Motley Fool
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
Zacks Investment Research
Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
Zacks Investment Research
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
Benzinga
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks Investment Research
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
Zacks Investment Research
J&J (JNJ) Seeks Expanded Use of Tremfya for Ulcerative Colitis
Zacks Investment Research
8 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
Benzinga
Rare Stock Picks In February 2024 - From 32 Discerning Analysts
Seeking Alpha
TEVA: 3 Pharma Stocks to Consider for March Gains - StockNews.com
StockNews.com
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Benzinga
Teva: Biosimilar to Humira Finally Seals US Approval; Looks to Be Best in Class in a Crowded Market - Morningstar
Morningstar
David Einhorn’s Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy
MarketWatch
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise
Benzinga
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
Benzinga
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
Beyond The Numbers: 8 Analysts Discuss Teva Pharmaceutical Indus Stock
Benzinga
TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
Zacks Investment Research
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
The Motley Fool
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
Benzinga
Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
Benzinga
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
Benzinga
Teva Earnings: Turnaround Year Ends With Strong Quarter as Sales Growth Returns - Morningstar
Morningstar
Unveiling Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Outlook: Wall Street Estimates for Key Metrics
Zacks Investment Research
Zacks Industry Outlook Highlights Amphastar, Teva and Dr. Reddy's
Zacks Investment Research
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks Investment Research
Capitalizzazione:
|
Volume (24 ore):